Schedule 13G ownership disclosure

AQUINOX PHARMACEUTICALS, INC

Security class unavailable · CUSIP: 03842B101

Event date: 2015-08-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,032,151
Percent of class
9.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-051513
Form type
SC 13G
Filer
Neurogene Inc.
CIK
CIK 1404644
Filed
Aug 24, 2015
Reporting period
Aug 14, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub